Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking

Nuclear Receptors as New Perspective for the Management of Liver Diseases

(2011) Michael Trauner et al.   GASTROENTEROLOGY

Nuclear receptors in liver disease

(2011) Martin Wagner et al.   HEPATOLOGY

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

The interaction between HCV and nuclear receptor-mediated pathways

(2011) Zoe Raglow et al.   PHARMACOLOGY & THERAPEUTICS

Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes

(2010) Li Ye et al.   DRUG AND ALCOHOL DEPENDENCE

Pathogenesis of alcoholic liver disease: the role of nuclear receptors

(2010) Maxwell Afari Gyamfi et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Abnormalities of lipid metabolism in hepatitis C virus infection

(2010) F. Negro   GUT

Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation

(2010) Sihao Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis

(2010) Xinran Ma et al.   JOURNAL OF HEPATOLOGY

Telaprevir for Previously Treated Chronic HCV Infection

(2010) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma

(2009) KyeongJin Kim et al.   FEBS LETTERS

Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man

(2009) Constantinos Christodoulides et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells

(2009) Yuki Nishimura-Sakurai et al.   JOURNAL OF GASTROENTEROLOGY

The role of proliferator-activated receptor γ coactivator–1α in the fatty-acid–dependent transcriptional control of interleukin-10 in hepatic cells of rodents

(2009) Joseane Morari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease

(2009) B. Dong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease

(2009) Tommaso Mello et al.   PPAR Research

Nuclear Receptors and Inflammatory Diseases

(2008) Kun Wang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production

(2008) Wei Yang et al.   HEPATOLOGY

Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2

(2008) J.-K. Oem et al.   JOURNAL OF GENERAL VIROLOGY

Nuclear Hormone Receptors for Heme: REV-ERBα and REV-ERBβ Are Ligand-Regulated Components of the Mammalian Clock

(2008) Thomas P. Burris   MOLECULAR ENDOCRINOLOGY

Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver

(2007) Javier García-Villafranca et al.   BIOCHIMIE

Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR

(2007) Caroline Scholtes et al.   JOURNAL OF HEPATOLOGY